Indian share market saw sharp selling on 28th August 2025 after new Trump tariffs on Indian exports put a dent in investors’ sentiment. Dull global cues, massive FII selling, and weakness in sectors pulled indices down, erasing nearly ₹3.9 lakh crore of investor wealth.
- BSE Sensex: Closed at 79,980, down by 700+ points
- NSE Nifty 50: Closed at 24,500, shattering important 24,600 support level
- Bank Nifty: Closed at 54,450, with 55,000 as a resistance
- India VIX: Increased 7%, reflecting increasing market volatility
- Foreign Institutional Investors (FIIs) maintained selling pressure, selling equities worth ₹6,516 crore.
- Domestic Institutional Investors (DIIs) maintained stability with decent flows of ₹7,060 crore, which checked further decline.
- Even as DII was purchasing, turnover in the cash market fell to less than ₹1 lakh crore, a six-month trough.
- Higher US tariffs on Indian exports led to an abrupt risk-off sentiment.
- Stocks with a focus on exports, especially textiles, IT and specialty chemicals, spearheaded the fall.
- Experts caution that Nifty's fall below its 50-day EMA with a bearish RSI crossover indicates on-going weakness.
- All 15 NSE industry groups fell in the red, the heaviest jolts in:
- Defence
- I.T.
- Realty
- Midcap and Smallcap indices also saw across-the-board selling.
- Textile shares plummeted, indicating tariff concerns.
- Pharma shares remained firm, with selective buying of defensive stocks against the weakness in the market.
- Adani Total Gas – dipped 3.85%
- IndiGo (InterGlobe Aviation) – lost 4.31%, following Gangwal family stake sale announcement of ₹7,000 crore
- Tata Steel – pulled down by global trade issues
- MCX – one of the day's top losers
- Shriram Finance – poor following selling in financial stocks
- IndiGo – watch on Gangwal family stake sale of ₹7,000 crore.
- Power Grid, BPCL, Oil India, RVNL – could see action on infra and energy space triggers.
- SMS Pharma – share to remain in limelight after it had received USFDA EIR (Establishment Inspection Report).
- BSE Ltd. – subsidiaries to be merged with BSE Technologies, value unlocking initiative expected.
- SMS Pharma: Positive trigger from USFDA compliance approval.
- BSE Technologies Merger: to de-complicate operations and inject efficiency into BSE's digital platforms.
- Investors lost almost ₹3.9 lakh crore in today's session as market-wide selling swept the markets.
- Market gurus point out that technical breakdown below 24,600 can contribute to further down unless institutional buying comes into play.
- Nifty 24,600 has turned short-term resistance; support next at 24,300.
- Bank Nifty trend cautious below 55,000.
- Volatility index reaching new highs indicates that traders need to be prepared for vicious intraday whipsaws.